cephalosporin c has been researched along with Soft Tissue Infections in 68 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (8.82) | 18.2507 |
| 2000's | 12 (17.65) | 29.6817 |
| 2010's | 40 (58.82) | 24.3611 |
| 2020's | 10 (14.71) | 2.80 |
| Authors | Studies |
|---|---|
| Carrothers, TJ; Esposito, S; Kantecki, M; Riccobene, T; Stone, GG | 1 |
| Castanheira, M; Duncan, LR; Mendes, RE; Sader, HS | 1 |
| Dryden, M; Kantecki, M; Leister-Tebbe, H; Stone, GG; Wilcox, M; Yan, JL | 1 |
| Gaviria-Mendoza, A; Gómez-Franco, JS; Machado-Alba, JE; Mafla-Ríos, YV; Martínez-García, MP; Parra-Muñoz, DA; Salazar-Cuevas, MC; Sepúlveda-Londoño, D | 1 |
| Giamarellos-Bourboulis, EJ; Leventogiannis, K; Mouktaroudi, M | 1 |
| Buonomo, AR; Gentile, I; Maraolo, AE; Mazzitelli, M; Torti, C; Trecarichi, EM | 1 |
| Buonomo, AR; Congera, P; Foggia, M; Gentile, I; Maraolo, AE; Parente, S; Scotto, R; Zappulo, E | 1 |
| Hsueh, PR; Jean, SS; Ko, WC | 1 |
| Hsueh, PR; Jean, SS; Ko, WC; Lee, WS | 1 |
| Cabañero-Navalón, MD; García-Bustos, V; Salavert Lletí, M | 1 |
| Bassetti, M; Castaldo, N; Givone, F; Peghin, M; Righi, E; Sartor, A | 1 |
| Arcenillas, P; Boix-Palop, L; Calbo, E; Cuchi, E; Dietl, B; Gómez, L; González de Molina, FJ; Nicolás, J; Sánchez, I | 1 |
| Jiménez-Delgado, JD; Monterrubio-Villar, J; Rodríguez-Garrido, S | 1 |
| Das, S; Iaconis, J; Li, J; Melnick, D; Stone, GG; Yan, JL; Zhou, D | 1 |
| Stone, GG; Urbán, E | 1 |
| Barberán, J | 1 |
| Farrell, DJ; Flamm, RK; Jones, RN; Sader, HS | 1 |
| Flamm, RK; Jones, RN; Sader, HS | 1 |
| Frampton, JE | 1 |
| Flamm, RK; Jones, RN; Pfaller, MA; Sader, HS | 1 |
| Bei, D; Chen, Z; Dong, L; Fan, J | 1 |
| Barberán, J; Cisneros, JM | 1 |
| Farrell, DJ; Flamm, RK; Jones, RN; Mendes, RE; Sader, HS | 1 |
| Eckmann, C | 2 |
| Albuszies, G; Klösel, S | 1 |
| Corey, GR; Jones, RN; Stryjewski, ME | 1 |
| Ahmed, S; Ali, SA; Arsalan, A; Naqvi, SB; Shakeel, O | 1 |
| Biedenbach, DJ; Bouchillon, SK; Iaconis, JP; Karlowsky, JA; Reiszner, E; Sahm, DF | 1 |
| Battersby, A; Gibson, E; Hackett, J; Karve, S; Levinson, J | 1 |
| Concia, E; Falcone, M; Giusti, M; Mazzone, A; Santini, C; Stefani, S; Violi, F | 1 |
| Hahn, AW; Jain, R; Spach, DH | 1 |
| Biedenbach, DJ; Bouchillon, SK; Hackel, M; Iaconis, JP; Karlowsky, JA; Sahm, DF | 1 |
| Dryden, M; Gonzalez, J; Iaconis, JP; Wilson, D; Zhang, Y | 1 |
| Scott, LJ | 1 |
| Crespo Casal, M; Martinez-Lamas, L; Nodar, A; Perez-Landeiro, A; Perez-Rodríguez, MT; Sousa Dominguez, A | 1 |
| Domínguez-Herrera, J; Labrador-Herrera, G; López-Rojas, R; Pachón, J; Smani, Y | 1 |
| Cohen, R; Gillet, Y; Moulin, F; Quinet, B; Raymond, J | 1 |
| Jones, RN; Mendes, RE; Sader, HS | 1 |
| Moellering, RC | 1 |
| Drusano, GL | 1 |
| Baculik, T; Corey, GR; Friedland, D; Talbot, GH; Thye, D; Wilcox, MH | 2 |
| Corrado, ML | 1 |
| Biek, D; Critchley, IA; Riccobene, TA; Thye, DA | 1 |
| Burd, EM; Ribner, BS; Shak, JR; Whitaker, JA | 1 |
| Jain, A; Kaushik, D; Rathi, S | 1 |
| Laudano, JB | 1 |
| Tuğrul, HM; Yıldırım, MI | 1 |
| Wilcox, MH | 1 |
| Giuliano, C; Johnson, LB; Kale-Pradhan, PB | 1 |
| Bucko, AD; Hom, R; Hunt, BJ; Kidd, SL | 1 |
| Gudiol, F; Marín, M | 1 |
| Naser, N; Shliapnikov, SA | 1 |
| Devcich, KJ; París, MM | 1 |
| Joseph, WS | 1 |
| Fritsche, TR; Jones, RN; Sader, HS; Streit, JM | 1 |
| Bowlware, KL; Ghaffar, F; Lozano-Hernandez, J; McCracken, GH | 1 |
| Jones, RN; Sader, HS | 1 |
| Doménech, L; Hernández-Martin, J; Poveda, JL; Romá, E; Salavert, M | 1 |
| Widmer, AF | 1 |
| Galloway, KP; Henry, SL | 1 |
| Nolen, T | 1 |
| Montero, L | 1 |
| Ito, K; Ito, M | 1 |
| Cordonnier, C; Delain, M; Delmer, A; Gardembas, M; Gres, JJ; Herbrecht, R; Ladeb, S; Moreau, P; Nalet, V; Pico, JL; Rollin, C | 1 |
| Alekseev, AA; Blatun, LA; Iakovlev, VP; Izotova, GN; Krutikov, MG; Puchkova, LS; Svetukhin, AM | 1 |
| Porcalla, AR; Rodriguez, WJ | 1 |
22 review(s) available for cephalosporin c and Soft Tissue Infections
| Article | Year |
|---|---|
Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.
Topics: Ceftaroline; Cephalosporins; Child; Humans; Infant, Newborn; Methicillin-Resistant Staphylococcus aureus; Pneumonia; Soft Tissue Infections | 2021 |
Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials.
Topics: Adult; Bacteremia; Ceftaroline; Cephalosporins; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Humans; Pneumonia; Soft Tissue Infections; Treatment Outcome | 2022 |
Clinical evidence supporting ceftaroline fosamil and ceftobiprole for complicated skin and soft tissue infections.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Soft Tissue Infections; Staphylococcal Infections | 2023 |
Ceftolozane/tazobactam for difficult-to-treat Pseudomonas aeruginosa infections: A systematic review of its efficacy and safety for off-label indications.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Intraabdominal Infections; Observational Studies as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Soft Tissue Infections; Tazobactam; Urinary Tract Infections | 2020 |
[Role of cefditoren in the treatment of community skin and soft tissue infections: revisiting the evidence].
Topics: Anti-Bacterial Agents; Cephalosporins; Humans; Soft Tissue Infections | 2021 |
Possible clinical indications of ceftobiprole.
Topics: Anti-Bacterial Agents; Bacterial Infections; Catheter-Related Infections; Cephalosporins; Cross Infection; Diabetic Foot; Fever of Unknown Origin; Humans; Inpatients; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections | 2019 |
Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Humans; Pneumonia; Skin Diseases, Infectious; Soft Tissue Infections | 2013 |
Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USA.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Drug Approval; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Product Surveillance, Postmarketing; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; United States | 2015 |
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Daptomycin; Female; Fluoroquinolones; Glycopeptides; Hospitalization; Humans; Iatrogenic Disease; Internal Medicine; Linezolid; Lipoglycopeptides; Male; Minocycline; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Teicoplanin; Tigecycline; Vancomycin | 2016 |
New Approaches to Antibiotic Use and Review of Recently Approved Antimicrobial Agents.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Bacterial Infections; Ceftaroline; Cephalosporins; Drug Administration Schedule; Drug Approval; Drug Combinations; Drug Resistance, Microbial; Glycopeptides; Humans; Lipoglycopeptides; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Soft Tissue Infections; Teicoplanin; United States; United States Food and Drug Administration | 2016 |
Ceftaroline Fosamil: A Review in Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.
Topics: Animals; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Community-Acquired Infections; Humans; Pneumonia; Soft Tissue Infections; Staphylococcal Skin Infections | 2016 |
Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.
Topics: Animals; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Clinical Trials, Phase III as Topic; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome | 2010 |
Ceftaroline: a comprehensive update.
Topics: Anti-Bacterial Agents; Bacteria; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Drug Approval; Humans; Pneumonia, Bacterial; Prodrugs; Skin Diseases, Bacterial; Soft Tissue Infections; United States | 2011 |
Ceftaroline fosamil: a new broad-spectrum cephalosporin.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Pneumonia, Bacterial; Prodrugs; Skin Diseases, Bacterial; Soft Tissue Infections; United States | 2011 |
MRSA new treatments on the horizon: current status.
Topics: Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Glycopeptides; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Teicoplanin | 2011 |
[Surgical infection of soft tissue--a problem of adequate antibiotic therapy].
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Diabetic Foot; Drug Therapy, Combination; Fasciitis, Necrotizing; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Soft Tissue Infections; Species Specificity; Surgical Wound Infection | 2003 |
Overview of cefdinir: pharmacokinetics, safety, and efficacy in the treatment of uncomplicated skin and skin structure infections.
Topics: Adult; Anti-Infective Agents; Cefdinir; Cephalosporins; Child; Humans; Skin Diseases, Bacterial; Soft Tissue Infections | 2004 |
Staphylococcal resistance and oral cephalosporins for skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Humans; Soft Tissue Infections; Staphylococcal Skin Infections; Streptococcal Infections; Streptococcus pyogenes | 2004 |
[Cefditoren pivoxil: A new oral cephalosporin for skin, soft tissue and respiratory tract infections].
Topics: Administration, Oral; Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Humans; Respiratory Tract Infections; Skin Diseases, Infectious; Soft Tissue Infections | 2006 |
Ceftobiprole: a new option for treatment of skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
Topics: Cephalosporins; Humans; Methicillin Resistance; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus | 2008 |
Local antibacterial therapy for the management of orthopaedic infections. Pharmacokinetic considerations.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bone Cements; Bone Diseases; Cephalosporins; Drug Delivery Systems; Humans; Methylmethacrylates; Microspheres; Osteomyelitis; Penicillins; Soft Tissue Infections; Vancomycin | 1995 |
Comparative studies of cefprozil in the management of skin and soft-tissue infections.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Skin Diseases, Bacterial; Soft Tissue Infections | 1994 |
9 trial(s) available for cephalosporin c and Soft Tissue Infections
| Article | Year |
|---|---|
A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Prospective Studies; Skin Diseases, Bacterial; Soft Tissue Infections; Systemic Inflammatory Response Syndrome; Treatment Outcome; Vancomycin; Young Adult | 2016 |
CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2010 |
CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2010 |
Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2010 |
Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefadroxil; Cefuroxime; Cephalosporins; Child; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Skin Diseases, Infectious; Soft Tissue Infections; Treatment Outcome | 2002 |
Cefdinir pharmacokinetics and tolerability in children receiving 25 mg/kg once daily.
Topics: Acute Disease; Anti-Infective Agents; Cefdinir; Cephalosporins; Child; Child, Preschool; Humans; Infant; Microbial Sensitivity Tests; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Respiratory Tract Infections; Soft Tissue Infections; Streptococcus pneumoniae; Treatment Outcome | 2006 |
A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and/or soft tissue infections.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cephalosporins; Child; Child, Preschool; Double-Blind Method; Female; Humans; Infant; Male; Skin Diseases, Infectious; Soft Tissue Infections | 1996 |
Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Gastrointestinal Diseases; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Male; Neutropenia; Skin Diseases, Bacterial; Soft Tissue Infections; Urinary Tract Infections | 1997 |
[Use of cefpirome in the treatment of patients with skin and soft tissue infections].
Topics: Adolescent; Adult; Burns; Cefpirome; Cephalosporins; Humans; Microbial Sensitivity Tests; Middle Aged; Necrosis; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Wound Infection | 1996 |
37 other study(ies) available for cephalosporin c and Soft Tissue Infections
| Article | Year |
|---|---|
Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Boronic Acids; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Soft Tissue Infections; Tazobactam | 2021 |
[Outpatient cephalosporin use in a Colombian population: prescription-indication study].
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Colombia; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Outpatients; Practice Patterns, Physicians'; Prescriptions; Respiratory Tract Infections; Soft Tissue Infections | 2021 |
Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Humans; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Tazobactam; Treatment Outcome | 2020 |
Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum β-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (AT
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftaroline; Cephalosporins; Drug Resistance, Bacterial; Humans; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Respiratory Tract Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Taiwan | 2020 |
In vitro susceptibility of ceftaroline against clinically important Gram-positive cocci, Haemophilus species and Klebsiella pneumoniae in Taiwan: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Haemophilus; Humans; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Respiratory Tract Infections; Soft Tissue Infections; Staphylococcus aureus; Taiwan | 2021 |
Multidrug-resistant Pseudomonas aeruginosa skin and soft-tissue infection successfully treated with ceftolozane/tazobactam.
Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Tazobactam; Treatment Outcome | 2017 |
Ceftolozane/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa: clinical and microbiological outcomes.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Osteomyelitis; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Skin Diseases, Bacterial; Soft Tissue Infections; Tazobactam; Treatment Outcome | 2018 |
Postoperative soft-tissue infection due to multidrug-resistant Pseudomonas aeruginosa: usefulness of ceftolozane-tazobactam.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Male; Middle Aged; Postoperative Complications; Pseudomonas aeruginosa; Pseudomonas Infections; Soft Tissue Infections; Tazobactam; Treatment Outcome | 2018 |
Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Child; Clinical Trials as Topic; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Young Adult | 2019 |
Impact of EUCAST ceftaroline breakpoint change on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from patients with complicated skin and soft-tissue infections.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Female; Global Health; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Soft Tissue Infections; Staphylococcal Skin Infections; Young Adult | 2019 |
Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010).
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Escherichia coli; Europe; Gram-Positive Cocci; Humans; Klebsiella; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Skin Infections | 2013 |
Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
Topics: Anti-Bacterial Agents; Asia; Ceftaroline; Cephalosporins; Community-Acquired Infections; Haemophilus influenzae; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Skin Diseases, Bacterial; Soft Tissue Infections; South Africa; Staphylococcus aureus; Streptococcus pneumoniae | 2013 |
Ceftaroline activity against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2009-2011).
Topics: Academic Medical Centers; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Soft Tissue Infections; United States | 2014 |
[Clinical characteristics and antimicrobial resistance of invasive group A β-hemolytic streptococcus infection in children].
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Clindamycin; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Retrospective Studies; Soft Tissue Infections; Streptococcal Infections; Streptococcus pyogenes | 2014 |
[Role of ceftaroline in skin and soft tissue infections].
Topics: Ceftaroline; Cephalosporins; Humans; Skin Diseases, Bacterial; Soft Tissue Infections | 2014 |
Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).
Topics: Adolescent; Anti-Bacterial Agents; Bacteria; Ceftaroline; Cephalosporins; Child; Child, Preschool; Drug Resistance, Bacterial; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Serotyping; Skin Diseases, Bacterial; Soft Tissue Infections | 2014 |
[Efficacy of ceftaroline in treating complicated skin and soft tissue infections].
Topics: Aztreonam; Ceftaroline; Cephalosporins; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Vancomycin | 2014 |
[Therapy of skin and soft tissue infections from surgeon's point of view].
Topics: Algorithms; Ceftaroline; Cephalosporins; Humans; Methicillin-Resistant Staphylococcus aureus; Opportunistic Infections; Postoperative Care; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections | 2014 |
[Two clinical example cases].
Topics: Aged; Arthroplasty, Replacement, Hip; Ceftaroline; Cephalosporins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Femoral Neck Fractures; Humans; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Opportunistic Infections; Reoperation; Soft Tissue Infections; Staphylococcal Infections; Surgical Wound Infection | 2014 |
In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cefpirome; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pakistan; Proteus; Proteus Infections; Respiratory Tract Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections | 2015 |
In vitro activity of ceftaroline against bacterial pathogens isolated from skin and soft tissue infections in Europe, Russia and Turkey in 2012: results from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programme.
Topics: Anti-Bacterial Agents; Bacteria; Ceftaroline; Cephalosporins; Drug Resistance, Bacterial; Epidemiological Monitoring; Europe; Humans; Microbial Sensitivity Tests; Prevalence; Skin Diseases, Bacterial; Soft Tissue Infections; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2016 |
Ceftaroline fosamil treatment outcomes compared with standard of care among hospitalized patients with complicated skin and soft tissue infections.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Humans; Retrospective Studies; Soft Tissue Infections; Standard of Care; Treatment Outcome | 2016 |
In vitro activity of Ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in African and Middle Eastern countries: AWARE global surveillance program 2012-2014.
Topics: Africa; Anti-Bacterial Agents; Bacteria; Ceftaroline; Cephalosporins; Epidemiological Monitoring; Humans; Microbial Sensitivity Tests; Middle East; Respiratory Tract Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2016 |
Successful treatment of MDR Pseudomonas aeruginosa skin and soft-tissue infection with ceftolozane/tazobactam.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Male; Middle Aged; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Tazobactam | 2017 |
Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Biofilms; Ceftaroline; Cephalosporins; Disease Models, Animal; Female; Foreign Bodies; Methicillin Resistance; Mice, Inbred C57BL; Microbial Sensitivity Tests; Random Allocation; Sepsis; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2016 |
[Managing children skin and soft tissue infections].
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cellulitis; Cephalosporins; Child; Drug Resistance, Bacterial; Fasciitis, Necrotizing; Furunculosis; Fusidic Acid; Humans; Impetigo; Injections, Intravenous; Macrolides; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Penicillins; Pristinamycin; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Scalded Skin Syndrome; Staphylococcal Skin Infections; Staphylococcus aureus; Stevens-Johnson Syndrome; Streptococcal Infections; Streptococcus pyogenes | 2008 |
Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Clinical Trials, Phase III as Topic; Europe; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Population Surveillance; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; United States | 2010 |
The problem of complicated skin and skin structure infections: the need for new agents.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Clinical Trials, Phase III as Topic; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Skin Infections | 2010 |
Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Half-Life; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections | 2010 |
Aminoglycoside-resistant Aeromonas hydrophila as part of a polymicrobial infection following a traumatic fall into freshwater.
Topics: Adult; Aeromonas hydrophila; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Resistance, Bacterial; Fresh Water; Humans; Male; Microbial Sensitivity Tests; Soft Tissue Infections; Tobramycin; Wounds and Injuries | 2011 |
[Assessment of efficacies of imipenem, cefoperazone-sulbactam and cefepime in rats with experimental thigh abscess model with multidrug resistant and susceptible Acinetobacter baumannii strains].
Topics: Abscess; Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Cefepime; Cefoperazone; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Imipenem; Random Allocation; Rats; Rats, Wistar; Serum Bactericidal Test; Soft Tissue Infections; Sulbactam; Thigh | 2011 |
Early response of ceftaroline fosamic in the treatment of soft-tissue infections.
Topics: Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Community-Acquired Infections; Endpoint Determination; Humans; Pneumonia; Randomized Controlled Trials as Topic; Retrospective Studies; Soft Tissue Infections; Time Factors; Treatment Outcome; Vancomycin | 2012 |
[beta-Lactam antibiotics].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Endocarditis, Bacterial; Humans; Molecular Structure; Monobactams; Neutropenia; Penicillins; Respiratory Tract Infections; Soft Tissue Infections; Staphylococcal Skin Infections; Urinary Tract Infections | 2003 |
Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolates.
Topics: Anti-Infective Agents; Bacteria; Cefdinir; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Gram-Positive Cocci; Humans; Klebsiella; Microbial Sensitivity Tests; North America; Skin Diseases, Bacterial; Soft Tissue Infections | 2004 |
Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: are we evaluating the orally administered cephalosporins correctly?
Topics: Administration, Oral; Anti-Infective Agents; Cefdinir; Cephalosporins; Drug Resistance, Bacterial; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Soft Tissue Infections | 2006 |
Microbiological and clinical studies on cefpodoxime proxetil for bacterial skin and soft tissue infections in pediatric patients.
Topics: Bacteria; Bacterial Infections; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Prodrugs; Skin Diseases, Infectious; Soft Tissue Infections | 1995 |
Soft tissue and cartilage infection by Salmonella oranienburg in a healthy girl.
Topics: Amoxicillin; Animals; Biopsy; Cartilage Diseases; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Female; Guinea Pigs; Humans; Microbial Sensitivity Tests; Penicillins; Rodent Diseases; Salmonella enterica; Salmonella Infections; Serotyping; Soft Tissue Infections; Tomography, X-Ray Computed | 2001 |